IAA
HELP

Independent Advisor Alliance’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Independent Advisor Alliance’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$462K Buy
+69,933
New +$350K 0.01% 695

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Independent Advisor Alliance's HELP Position: Q2 2026 in Review

Independent Advisor Alliance opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 69,933 shares worth $462K. The stake represents 0.01% of the portfolio and ranks #695 among its holdings.

99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Independent Advisor Alliance held 69,933 shares of Helus Pharma Inc. Common Stock worth $462K as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new Independent Advisor Alliance position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up 0.01% of Independent Advisor Alliance's portfolio in Q2 2026, its #695 holding.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.